Latest Breaking News On - பகுப்பாய்வு முடிவுகள் - Page 6 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and . Tonix Pharmaceuticals Holding Corp.March 15, 2021 GMT Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia Interim Analysis Results from Second Confirmatory Phase 3 Study, RALLY, Expected in Third Quarter 2021: Interim Cohort Enrolled Efficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in First Quarter 2021 Phase 1 Safety Study in Humans of TNX-1800 Expected to Start in Second Half 2021 At December 31, 2020, Cash and Cash Equivalents Totaled $77.1 Million;  Approximately $110 Million in Gross Proceeds Raised Subsequent to Year-End

United statesJessica morrisSeth ledermanOlipriya dasPeter vozzoTonix pharmaceuticalsTonix pharmaceuticals reports fourth quarterFrench national institute of healthDrug administrationExchange commissionTrigemina incTonix pharmaceuticals holding corpUniversity of genevaAnnounced positive phaseAnalysis resultsSecond confirmatory phase